Literature DB >> 26909232

Role of Helicobacter pylori infection in pathogenesis of gastric carcinoma.

Rong-Guang Zhang1, Guang-Cai Duan1, Qing-Tang Fan1, Shuai-Yin Chen1.   

Abstract

Gastric cancer (GC) is one of the most common carcinoma and the second leading cause of cancer-related deaths worldwide. Helicobacter pylori (H. pylori) infection causes a series of precancerous lesions like gastritis, atrophy, intestinal metaplasia and dysplasia, and is the strongest known risk factor for GC, as supported by epidemiological, preclinical and clinical studies. However, the mechanism of H. pylori developing gastric carcinoma has not been well defined. Among infected individuals, approximately 10% develop severe gastric lesions such as peptic ulcer disease, 1%-3% progresses to GC. The outcomes of H. pylori infection are determined by bacterial virulence, genetic polymorphism of hosts as well as environmental factors. It is important to gain further understanding of the pathogenesis of H. pylori infection for developing more effective treatments for this common but deadly malignancy. The recent findings on the bacterial virulence factors, effects of H. pylori on epithelial cells, genetic polymorphism of both the bacterium and its host, and the environmental factors for GC are discussed with focus on the role of H. pylori in gastric carcinogenesis in this review.

Entities:  

Keywords:  Environmental factors; Gastric cancer; Genetic polymorphism; Helicobacter pylori; Virulence factors

Year:  2016        PMID: 26909232      PMCID: PMC4753193          DOI: 10.4291/wjgp.v7.i1.97

Source DB:  PubMed          Journal:  World J Gastrointest Pathophysiol        ISSN: 2150-5330


  103 in total

1.  Cytokine expression and production by purified Helicobacter pylori urease in human gastric epithelial cells.

Authors:  T Tanahashi; M Kita; T Kodama; Y Yamaoka; N Sawai; T Ohno; S Mitsufuji; Y P Wei; K Kashima; J Imanishi
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  vacA i-region subtyping.

Authors:  Hiroaki Ogiwara; David Y Graham; Yoshio Yamaoka
Journal:  Gastroenterology       Date:  2008-02-08       Impact factor: 22.682

3.  Helicobacter pylori CagA interacts with E-cadherin and deregulates the beta-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells.

Authors:  N Murata-Kamiya; Y Kurashima; Y Teishikata; Y Yamahashi; Y Saito; H Higashi; H Aburatani; T Akiyama; R M Peek; T Azuma; M Hatakeyama
Journal:  Oncogene       Date:  2007-01-22       Impact factor: 9.867

4.  Association between polymorphisms in interleukin-17A and interleukin-17F genes and risks of gastric cancer.

Authors:  Xiaoqin Wu; Zhirong Zeng; Bin Chen; Jun Yu; Ling Xue; Yuantao Hao; Minhu Chen; Joseph J Y Sung; Pinjin Hu
Journal:  Int J Cancer       Date:  2010-07-01       Impact factor: 7.396

Review 5.  The role of the gastrointestinal microbiome in Helicobacter pylori pathogenesis.

Authors:  Alexander Sheh; James G Fox
Journal:  Gut Microbes       Date:  2013-08-19

6.  "Targeted disruption of the epithelial-barrier by Helicobacter pylori".

Authors:  Lydia E Wroblewski; Richard M Peek
Journal:  Cell Commun Signal       Date:  2011-11-01       Impact factor: 5.712

7.  Molecular mechanisms of gastric epithelial cell adhesion and injection of CagA by Helicobacter pylori.

Authors:  Steffen Backert; Marguerite Clyne; Nicole Tegtmeyer
Journal:  Cell Commun Signal       Date:  2011-11-01       Impact factor: 5.712

8.  Effect of Di(2-ethylhexyl)phthalate on Helicobacter pylori-Induced Apoptosis in AGS Cells.

Authors:  Chuang-Hao Lin; Chien-Yi Wu; Hwang-Shang Kou; Chiao-Yun Chen; Meng-Chuan Huang; Huang-Ming Hu; Meng-Chieh Wu; Chien-Yu Lu; Deng-Chyang Wu; Ming-Tsang Wu; Fu-Chen Kuo
Journal:  Gastroenterol Res Pract       Date:  2013-12-16       Impact factor: 2.260

9.  Modelling human development and disease in pluripotent stem-cell-derived gastric organoids.

Authors:  Kyle W McCracken; Emily M Catá; Calyn M Crawford; Katie L Sinagoga; Michael Schumacher; Briana E Rockich; Yu-Hwai Tsai; Christopher N Mayhew; Jason R Spence; Yana Zavros; James M Wells
Journal:  Nature       Date:  2014-10-29       Impact factor: 49.962

Review 10.  Remodeling the host environment: modulation of the gastric epithelium by the Helicobacter pylori vacuolating toxin (VacA).

Authors:  Ik-Jung Kim; Steven R Blanke
Journal:  Front Cell Infect Microbiol       Date:  2012-03-27       Impact factor: 5.293

View more
  25 in total

1.  Association between cagA, vacAi, and dupA genes of Helicobacter pylori and gastroduodenal pathologies in Chilean patients.

Authors:  Esteban Paredes-Osses; Katia Sáez; Enrique Sanhueza; Sonja Hebel; Carlos González; Carlos Briceño; Apolinaria García Cancino
Journal:  Folia Microbiol (Praha)       Date:  2017-03-11       Impact factor: 2.099

2.  Dynamics of Oxidative Stress in Helicobacter pylori-Positive Patients with Atrophic Body Gastritis and Various Stages of Gastric Cancer.

Authors:  Vladislav Vladimirovich Tsukanov; Olga Valentinovna Smirnova; Edward Vilyamovich Kasparov; Alexander Alexandrovich Sinyakov; Alexander Viktorovich Vasyutin; Julia Leongardovna Tonkikh; Mikhail Alexandrovich Cherepnin
Journal:  Diagnostics (Basel)       Date:  2022-05-11

3.  Clinicopathological evaluation of Sox10 expression in diffuse-type gastric adenocarcinoma.

Authors:  Marin Kato; Hiroshi Nishihara; Hideyuki Hayashi; Taichi Kimura; Yusuke Ishida; Lei Wang; Masumi Tsuda; Mishie Ann Tanino; Shinya Tanaka
Journal:  Med Oncol       Date:  2016-12-10       Impact factor: 3.064

4.  Antibiotic resistance of Helicobacter pylori to 16 antibiotics in clinical patients.

Authors:  Yongfu Shao; Rongdan Lu; Yunben Yang; Qiancheng Xu; Bojun Wang; Guoliang Ye
Journal:  J Clin Lab Anal       Date:  2017-10-06       Impact factor: 2.352

5.  Prevalence of the colonization of Helicobacter pylori among students of the school of dentistry, University of Granada, Spain.

Authors:  J Liébana; V García-Casas; F Liébana-Cabanillas; M-T Arias-Moliz
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2016-09-01

6.  MiR-27a rs895819 is involved in increased atrophic gastritis risk, improved gastric cancer prognosis and negative interaction with Helicobacter pylori.

Authors:  Qian Xu; Tie-Jun Chen; Cai-Yun He; Li-Ping Sun; Jing-Wei Liu; Yuan Yuan
Journal:  Sci Rep       Date:  2017-02-02       Impact factor: 4.379

7.  Male non-insulin users with type 2 diabetes mellitus are predisposed to gastric corpus-predominant inflammation after H. pylori infection.

Authors:  Yao-Jong Yang; Chung-Tai Wu; Horng-Yih Ou; Chin-Han Lin; Hsiu-Chi Cheng; Wei-Lun Chang; Wei-Ying Chen; Hsiao-Bai Yang; Cheng-Chan Lu; Bor-Shyang Sheu
Journal:  J Biomed Sci       Date:  2017-10-30       Impact factor: 8.410

8.  Helicobacter pylori virulence dupA gene: risk factor or protective factor?

Authors:  Lucas Luiz de Lima Silva; Ana Karoline Silva Oliveira; Aline Rodrigues Gama; Amanda Ferreira Paes Landim Ramos; Antonio Márcio Teodoro Cordeiro Silva; Angel José Vieira Blanco; José Daniel Gonçalves Vieira; Lucas Trevizani Rasmussem; Lilian Carla Carneiro; Mônica Santiago Barbosa
Journal:  Braz J Microbiol       Date:  2021-07-13       Impact factor: 2.214

9.  Genetic polymorphisms in TNIP1 increase the risk of gastric carcinoma.

Authors:  Zhao Liu; Yuting Shi; Yuyan Na; Qi Zhang; Sizhe Cao; Xianglong Duan; Xiyang Zhang; Hua Yang; Tianbo Jin; Yiming Li
Journal:  Oncotarget       Date:  2016-06-28

10.  Cost-effectiveness analysis of two routine therapeutic methods for Helicobacter pylori eradication: a Persian cohort-based study.

Authors:  Farhad Pourfarzi; Telma Zahirian Moghadam; Hamed Zandian; Reza Malekzadeh; Abbas Yazdanbod
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.